GrantAuthority

Open

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Grant from National Institutes of Health

Funder
National Institutes of Health
Deadline
November 16, 2029
Status
Open
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
Official source
grants.gov

Open in GrantAuthority. The full listing, application link, requirements, attachments, program contacts and your organization's fit score are available with a free account.